Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2012 1
2013 4
2014 8
2015 11
2016 9
2017 5
2018 3
2019 5
2020 12
2021 16
2022 44
2023 28
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer.
Dilawari A, Shah M, Ison G, Gittleman H, Fiero MH, Shah A, Hamed SS, Qiu J, Yu J, Manheng W, Ricks TK, Pragani R, Arudchandran A, Patel P, Zaman S, Roy A, Kalavar S, Ghosh S, Pierce WF, Rahman NA, Tang S, Mixter BD, Kluetz PG, Pazdur R, Amiri-Kordestani L. Dilawari A, et al. Among authors: roy a. Clin Cancer Res. 2023 Oct 2;29(19):3835-3840. doi: 10.1158/1078-0432.CCR-23-0991. Clin Cancer Res. 2023. PMID: 37212825 Free PMC article.
Herd Immunity Against Coronavirus: A Review.
Datta S, Roy A. Datta S, et al. Among authors: roy a. Recent Pat Biotechnol. 2022 Aug 3;16(3):256-265. doi: 10.2174/1872208316666220408113002. Recent Pat Biotechnol. 2022. PMID: 35400332 Review.
Cyclodextrin nanoparticles in targeted cancer theranostics.
Bose R, Jayawant M, Raut R, Lakkakula J, Roy A, Alghamdi S, Qusty NF, Sharma R, Verma D, Khandaker MU, Almujally A, Tamam N, Sulieman A. Bose R, et al. Among authors: roy a. Front Pharmacol. 2023 Aug 3;14:1218867. doi: 10.3389/fphar.2023.1218867. eCollection 2023. Front Pharmacol. 2023. PMID: 37601050 Free PMC article. Review.
Current Prospects of Nutraceuticals: A Review.
Sachdeva V, Roy A, Bharadvaja N. Sachdeva V, et al. Among authors: roy a. Curr Pharm Biotechnol. 2020;21(10):884-896. doi: 10.2174/1389201021666200130113441. Curr Pharm Biotechnol. 2020. PMID: 32000642 Review.
Medicinal Plants against Ischemic Stroke.
Roy A, Datta S. Roy A, et al. Curr Pharm Biotechnol. 2021;22(10):1302-1314. doi: 10.2174/1389201021999201209222132. Curr Pharm Biotechnol. 2021. PMID: 33302829 Review.
An Overview of Nanomaterial Applications in Pharmacology.
Roy M, Roy A, Rustagi S, Pandey N. Roy M, et al. Among authors: roy a. Biomed Res Int. 2023 Jun 21;2023:4838043. doi: 10.1155/2023/4838043. eCollection 2023. Biomed Res Int. 2023. PMID: 37388336 Free PMC article. Review.
Role of Cannabinoids in Various Diseases: A Review.
Kaur S, Sharma N, Roy A. Kaur S, et al. Among authors: roy a. Curr Pharm Biotechnol. 2022;23(11):1346-1358. doi: 10.2174/1389201023666211223164656. Curr Pharm Biotechnol. 2022. PMID: 34951355 Review.
Biologically Derived Gold Nanoparticles and Their Applications.
Roy A, Pandit C, Gacem A, Alqahtani MS, Bilal M, Islam S, Hossain MJ, Jameel M. Roy A, et al. Bioinorg Chem Appl. 2022 Aug 1;2022:8184217. doi: 10.1155/2022/8184217. eCollection 2022. Bioinorg Chem Appl. 2022. PMID: 35959230 Free PMC article. Review.
145 results